Transforming growth factor‐beta inhibits proliferation of human ovarian cancer cells obtained from ascites

Background. Previously, the authors found that immortalized ovarian cancer cell lines generally were resistant to the growth inhibitory effect of transforming growth factor‐β and frequently had lost the ability to produce or activate this growth factor. In this study, the authors examined whether early passage epithelial ovarian cancer cells obtained from ascites are growth‐inhibited by or produce transforming growth factor‐β.

[1]  F. Ruscetti,et al.  Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. , 1988, Blood.

[2]  R. Berkowitz,et al.  Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. , 1993, Cancer research.

[3]  R. Berkowitz,et al.  Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors. , 1991, Anticancer research.

[4]  T. Dexter,et al.  Growth inhibitory effects of transforming growth factor-beta 1 in vivo. , 1991, Growth factors.

[5]  S. Thorgeirsson,et al.  Altered responsiveness of rat liver epithelial cells to transforming growth factor beta 1 following their transformation with v-raf. , 1990, Cancer research.

[6]  J. Dasch,et al.  Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. , 1989, Journal of immunology.

[7]  M. Reiss,et al.  Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis. , 1993, Critical reviews in oncogenesis.

[8]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[9]  Medicine,et al.  Overexpression and mutation of p53 in epithelial ovarian cancer. , 1991, Cancer research.

[10]  C. Marth,et al.  Transforming growth factor-beta and ovarian carcinoma cells: regulation of proliferation and surface antigen expression. , 1990, Cancer letters.

[11]  T. Hoang,et al.  Transforming growth factor beta inhibits the proliferation of the blast cells of acute myeloblastic leukemia. , 1988 .

[12]  R. Weinberg,et al.  Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells. , 1988, Science.

[13]  B. Monsarrat,et al.  Transforming growth factor β1 (TGF‐β1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors , 1992 .

[14]  J. McPherson,et al.  Unusual antiproliferative effects of transforming growth factors-β 1 andβ 2 against primary cells from human tumors , 1989 .

[15]  F. Hahn,et al.  Increased resistance to transforming growth factor beta accompanies neoplastic progression of rat tracheal epithelial cells. , 1989, Carcinogenesis.

[16]  Li Zhou,et al.  Growth regulation of ovarian cancer cells by epidermal growth factor and tranforming growth factors α and β1 , 1992 .

[17]  R. Bast,et al.  Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. , 1993, Journal of the National Cancer Institute.

[18]  S. Bates,et al.  Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. , 1989, Cancer research.

[19]  P. Humphrey,et al.  Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. , 1992, Journal of the National Cancer Institute.

[20]  R. Bast,et al.  The Role of Peptide Growth Factors in Epithelial Ovarian Cancer , 1990, Obstetrics and gynecology.

[21]  J. Massagué Receptors for the TGF-β family , 1992, Cell.

[22]  R. Bast,et al.  Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum. , 1983, Cancer research.

[23]  P. Yaciuk,et al.  TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains , 1990, Cell.

[24]  J. Bartlett,et al.  Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells. , 1992, British Journal of Cancer.

[25]  R. Bast,et al.  Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta. , 1992, American journal of obstetrics and gynecology.